Biofarm S.A. (BVB:BIO)
Romania · Delayed Price · Currency is RON 1.245
0.00 (0.00%)
At close: Apr 7, 2026
Biofarm Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 319.33 | 286.77 | 280.29 | 276.98 | 239.04 |
| 319.33 | 286.77 | 280.29 | 276.98 | 239.04 | |
Revenue Growth (YoY) | 11.36% | 2.31% | 1.19% | 15.87% | 10.45% |
Cost of Revenue | 48.92 | 47.15 | 49.98 | 45.69 | 40.44 |
Gross Profit | 270.41 | 239.62 | 230.31 | 231.29 | 198.6 |
Selling, General & Admin | 120.23 | 108.6 | 109.68 | 105.69 | 90.13 |
Amortization of Goodwill & Intangibles | - | - | - | - | 13.32 |
Other Operating Expenses | 35.6 | 36.13 | 28.86 | 33.14 | 26.29 |
Operating Expenses | 174.31 | 161.62 | 153.06 | 154.18 | 129.74 |
Operating Income | 96.11 | 78 | 77.25 | 77.11 | 68.87 |
Interest Expense | - | - | -0 | -0 | -0 |
Interest & Investment Income | 9.1 | 6.41 | 6.88 | 3.14 | 0.88 |
Currency Exchange Gain (Loss) | -0.78 | 0.23 | -0.16 | - | - |
EBT Excluding Unusual Items | 104.43 | 84.64 | 83.97 | 80.25 | 69.74 |
Gain (Loss) on Sale of Assets | -0 | -0 | -0.01 | - | -0.19 |
Asset Writedown | 10.78 | - | - | 1.84 | - |
Legal Settlements | -0.22 | -0.11 | -0.25 | -1.21 | - |
Pretax Income | 114.99 | 84.53 | 83.71 | 80.88 | 69.55 |
Income Tax Expense | 14.35 | 10.13 | 6.7 | 9.96 | 9.2 |
Net Income | 100.63 | 74.4 | 77.01 | 70.92 | 60.36 |
Net Income to Common | 100.63 | 74.4 | 77.01 | 70.92 | 60.36 |
Net Income Growth | 35.27% | -3.40% | 8.60% | 17.50% | 11.22% |
Shares Outstanding (Basic) | 985 | 985 | 985 | 985 | 985 |
Shares Outstanding (Diluted) | 1,093 | 1,085 | 1,080 | 1,071 | 1,061 |
Shares Change (YoY) | 0.75% | 0.40% | 0.83% | 1.01% | 0.34% |
EPS (Basic) | 0.10 | 0.08 | 0.08 | 0.07 | 0.06 |
EPS (Diluted) | 0.09 | 0.07 | 0.07 | 0.07 | 0.06 |
EPS Growth | 34.26% | -3.79% | 7.70% | 16.35% | 10.92% |
Free Cash Flow | 65.86 | 34.18 | 49.99 | -1.11 | 47.73 |
Free Cash Flow Per Share | 0.06 | 0.03 | 0.05 | -0.00 | 0.04 |
Dividend Per Share | - | 0.031 | 0.031 | 0.030 | 0.024 |
Dividend Growth | - | - | 3.33% | 25.00% | 9.09% |
Gross Margin | 84.68% | 83.56% | 82.17% | 83.50% | 83.08% |
Operating Margin | 30.10% | 27.20% | 27.56% | 27.84% | 28.81% |
Profit Margin | 31.51% | 25.94% | 27.48% | 25.60% | 25.25% |
Free Cash Flow Margin | 20.62% | 11.92% | 17.83% | -0.40% | 19.97% |
EBITDA | 114.64 | 95.03 | 94.21 | 92.61 | 82.59 |
EBITDA Margin | 35.90% | 33.14% | 33.61% | 33.44% | 34.55% |
D&A For EBITDA | 18.53 | 17.03 | 16.96 | 15.5 | 13.73 |
EBIT | 96.11 | 78 | 77.25 | 77.11 | 68.87 |
EBIT Margin | 30.10% | 27.20% | 27.56% | 27.84% | 28.81% |
Effective Tax Rate | 12.48% | 11.98% | 8.00% | 12.32% | 13.23% |
Advertising Expenses | 61.31 | 56.68 | 56.87 | 57.89 | 48.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.